Ulcerative Colitis
SHIFT-UC Clinical Research Study

Are you an adult with Ulcerative Colitis currently experiencing symptoms?

If yes, you may qualify for this clinical trial.

Sign up today to see if you qualify for this study.

  • Ulcerative Colitis Clinical Study Signup Form

  • This field is for validation purposes and should be left unchanged.

What is a clinical research study?

A clinical research study is a medical investigation that is designed to answer specific questions about potential new drugs (called “investigational drugs”). These questions may include how safe and effective an investigational drug is for use in a particular condition or disease. 

Every medication that you have been prescribed by a doctor will have undergone  rigorous testing in clinical research studies. Without clinical research studies,  there would be no real medical advances and no new treatment options would  become available. 

Taking part in a clinical research study is a big decision and your participation is voluntary. It is important that  you understand what participation will involve before you agree to take part. 

 

About the SHIFT-UC Study

Study Name: SHIFT-UC (GB004-2101)
Primary Investigator: Jacque Noel, III, MD
Study Site: Combined Gastro Research
Location: Lafayette, LA

Ulcerative colitis occurs when the body’s natural immune system attacks the cells and tissues in the large intestine. Several medications are available to doctors for treating patients with ulcerative colitis. However, not all patients respond to the available treatments and some may experience side effects. GB004-2101 is being developed as an oral (tablet) therapy that is being studied for its effects on gut healing and inflammation. All risks for the clinical research study will be discussed with you.

The SHIFT-UC Study will evaluate how safe and effective the investigational medication (GB004) is in treating patients with mild-to-moderate ulcerative colitis when added to background UC therapy of 5-aminosalicylate (5-ASA) with or without steroids. GB004 has already been tested in a limited number of people with ulcerative colitis, but this study will provide further important information.

 

Can you participate?

A study doctor will need to review your medical history and carry out some additional health checks before deciding whether this study is right for you. You may be able to take part in the SHIFT-UC Study if you:

  • Are 18 years of age or older
  • Have been diagnosed with ulcerative colitis
  • Are currently experiencing symptoms of ulcerative colitis

If you would like more information about the SHIFT-UC Study, please fill out the Ulcerative Colitis Clinical Study Signup Form on this page. All information collected will follow federal regulations called HIPAA while protecting your privacy.